ESR1 and breast carcinoma: Then, we calculated the t-statistics for two comparisons: (1) estrogen receptor-positive (ER+) versus estrogen receptor-negative (ER-) subtypes of breast cancer cell lines, and (2) prostate adenocarcinoma versus normal prostate tissue.